• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀的抗动脉粥样硬化作用取决于载脂蛋白E的存在。

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.

作者信息

Wang Yi Xin, Martin-McNulty Baby, Huw Ling Yuh, da Cunha Valdeci, Post Joe, Hinchman Josephine, Vergona Ronald, Sullivan Mark E, Dole William, Kauser Katalin

机构信息

Department of Pharmacology, Berlex Biosciences, P.O. Box 4099, 15049 San Pablo Avenue 15049 San Pablo Avenue, Richmond, CA 94804-0099, USA.

出版信息

Atherosclerosis. 2002 May;162(1):23-31. doi: 10.1016/s0021-9150(01)00678-5.

DOI:10.1016/s0021-9150(01)00678-5
PMID:11947894
Abstract

Low density lipoprotein receptor deficient (LDLR-KO) and apolipoprotein E deficient (apo E-KO) mice both develop hyperlipidemia and atherosclerosis by different mechanisms. The aim of the present study was to compare the effects of simvastatin on cholesterol levels, endothelial dysfunction, and aortic lesions in these two models of experimental atherosclerosis. Male LDLR-KO mice fed a high cholesterol (HC; 1%) diet developed atherosclerosis at 8 months of age with hypercholesterolemia. The addition of simvastatin (300 mg/kg daily) to the HC diet for 2 more months lowered total cholesterol levels by approximately 57% and reduced aortic plaque area by approximately 15% compared with the LDLR-KO mice continued on HC diet alone, P<0.05. Simvastatin treatment also improved acetylcholine (ACh)-induced endothelium-dependent vasorelaxation in isolated aortic rings, which was associated with an increase in NOS-3 expression by approximately 88% in the aorta measured by real time polymerase chain reaction (PCR), P<0.05. In contrast, in age-matched male apo E-KO mice fed a normal diet, the same treatment of simvastatin elevated serum total cholesterol by approximately 35%, increased aortic plaque area by approximately 15%, and had no effect on endothelial function. These results suggest that the therapeutic effects of simvastatin may depend on the presence of a functional apolipoprotein E.

摘要

低密度脂蛋白受体缺陷(LDLR-KO)小鼠和载脂蛋白E缺陷(apo E-KO)小鼠均通过不同机制发生高脂血症和动脉粥样硬化。本研究的目的是比较辛伐他汀对这两种实验性动脉粥样硬化模型中胆固醇水平、内皮功能障碍和主动脉病变的影响。喂食高胆固醇(HC;1%)饮食的雄性LDLR-KO小鼠在8个月大时出现动脉粥样硬化并伴有高胆固醇血症。在HC饮食中再添加辛伐他汀(每日300 mg/kg)2个月,与仅继续喂食HC饮食的LDLR-KO小鼠相比,总胆固醇水平降低了约57%,主动脉斑块面积减少了约15%,P<0.05。辛伐他汀治疗还改善了离体主动脉环中乙酰胆碱(ACh)诱导的内皮依赖性血管舒张,通过实时聚合酶链反应(PCR)测量,这与主动脉中一氧化氮合酶3(NOS-3)表达增加约88%相关,P<0.05。相比之下,在喂食正常饮食的年龄匹配雄性apo E-KO小鼠中,相同的辛伐他汀治疗使血清总胆固醇升高了约35%,主动脉斑块面积增加了约15%,并且对内皮功能没有影响。这些结果表明,辛伐他汀的治疗效果可能取决于功能性载脂蛋白E的存在。

相似文献

1
Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.辛伐他汀的抗动脉粥样硬化作用取决于载脂蛋白E的存在。
Atherosclerosis. 2002 May;162(1):23-31. doi: 10.1016/s0021-9150(01)00678-5.
2
Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.基因改变的高脂血症小鼠的动脉粥样硬化、血管重塑及内皮依赖性舒张功能受损
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2333-40. doi: 10.1161/01.atv.17.11.2333.
3
[Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].[通心络与辛伐他汀对兔主动脉粥样硬化易损斑块稳定性的影响及其分子机制:一项对比研究]
Zhonghua Yi Xue Za Zhi. 2006 Nov 28;86(44):3146-50.
4
Low Dose of Emodin Inhibits Hypercholesterolemia in a Rat Model of High Cholesterol.低剂量大黄素抑制高胆固醇血症大鼠模型中的高胆固醇血症。
Med Sci Monit. 2021 Jul 14;27:e929346. doi: 10.12659/MSM.929346.
5
A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.一种HMG-CoA还原酶抑制剂除具有降低血脂作用外,还具有强大的抗动脉粥样硬化作用——内皮型一氧化氮合酶和超氧阴离子清除作用的相关性。
Atherosclerosis. 2001 Apr;155(2):347-57. doi: 10.1016/s0021-9150(00)00597-9.
6
Aerobic exercise training protects against endothelial dysfunction by increasing nitric oxide and hydrogen peroxide production in LDL receptor-deficient mice.有氧运动训练通过增加低密度脂蛋白受体缺陷小鼠体内一氧化氮和过氧化氢的生成来预防内皮功能障碍。
J Transl Med. 2016 Jul 19;14(1):213. doi: 10.1186/s12967-016-0972-z.
7
Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.内皮素受体阻断可减轻载脂蛋白E缺乏小鼠的饮食诱导性高胆固醇血症和动脉粥样硬化。
Pathobiology. 2001;69(1):1-10. doi: 10.1159/000048751.
8
Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.早期高胆固醇血症可导致血管舒缩功能障碍和损伤相关的动脉粥样硬化形成,而一氧化氮可抑制这一过程。
J Vasc Surg. 2011 Mar;53(3):754-63. doi: 10.1016/j.jvs.2010.09.038. Epub 2010 Dec 15.
9
Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice.通过在载脂蛋白E缺陷和低密度脂蛋白受体缺陷小鼠中放置颈动脉血管周围套环诱导快速动脉粥样硬化形成。
Circulation. 2001 Feb 27;103(8):1164-70. doi: 10.1161/01.cir.103.8.1164.
10
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.瑞舒伐他汀与阿托伐他汀、辛伐他汀及普伐他汀对高胆固醇血症患者非高密度脂蛋白胆固醇、载脂蛋白及脂质比值的影响:STELLAR试验的额外结果
Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006.

引用本文的文献

1
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution.基于纳米颗粒的衣康酸盐疗法再现了低胆固醇/低脂饮食诱导的动脉粥样硬化斑块消退。
Cell Rep. 2024 Nov 26;43(11):114911. doi: 10.1016/j.celrep.2024.114911. Epub 2024 Oct 28.
2
The -Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR Mice by Improving Hyperlipidemia.源自 的多糖CM1通过改善高脂血症减轻LDLR小鼠的动脉粥样硬化。 (这里原文有个破折号前面内容缺失,导致句子不太完整准确)
Front Mol Biosci. 2021 Dec 13;8:783807. doi: 10.3389/fmolb.2021.783807. eCollection 2021.
3
Statins and Atherosclerotic Lesion Microcalcification: A New Mechanism for Plaque Stability?
他汀类药物与动脉粥样硬化病变微钙化:斑块稳定性的新机制?
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1306-1308. doi: 10.1161/ATVBAHA.121.315949. Epub 2021 Mar 24.
4
Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice.他汀类药物对血管钙化的影响:老年高脂血症小鼠主动脉钙沉积的微观结构变化。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):e185-e192. doi: 10.1161/ATVBAHA.120.315737. Epub 2021 Jan 21.
5
Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE Mice.亮肤氨酸通过抑制肝细胞和载脂蛋白 E 小鼠中 PCSK9 的表达来提高辛伐他汀的 LDL-C 降低效果。
Molecules. 2019 Nov 15;24(22):4140. doi: 10.3390/molecules24224140.
6
Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.普伐他汀可使巨噬细胞表型向M2极化,并升高载脂蛋白E基因敲除小鼠的血清胆固醇水平。
J Int Med Res. 2018 Aug;46(8):3365-3373. doi: 10.1177/0300060518787671. Epub 2018 Jul 29.
7
Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice.益瑞胶囊通过改善脂代谢和减轻载脂蛋白 E 缺乏小鼠的炎症反应缓解动脉粥样硬化。
Nutrients. 2018 Jan 29;10(2):142. doi: 10.3390/nu10020142.
8
Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.瑞舒伐他汀独立于降低血浆胆固醇水平减少载脂蛋白 E/清道夫受体 B1 双重基因敲除小鼠主动脉窦和冠状动脉粥样硬化
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):26-39. doi: 10.1161/ATVBAHA.117.305140. Epub 2017 Nov 21.
9
Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation.通过过表达腺相关病毒介导的前蛋白转化酶枯草溶菌素9(PCSK9)和部分颈动脉结扎加速C57Bl6小鼠动脉粥样硬化的发展。
Lab Invest. 2017 Aug;97(8):935-945. doi: 10.1038/labinvest.2017.47. Epub 2017 May 15.
10
Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment.在接受辛伐他汀治疗的小鼠中,骨骼肌对耐力运动训练的代谢适应性是可以实现的。
PLoS One. 2017 Feb 16;12(2):e0172551. doi: 10.1371/journal.pone.0172551. eCollection 2017.